Average Co-Inventor Count = 5.24
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Kymab Limited (14 from 103 patents)
2. Domantis Limited (11 from 38 patents)
3. Bristol-myers Squibb Compnay (5 from 3,681 patents)
4. Glaxo Group Limited (1 from 1,168 patents)
5. Bristol Meyers Squibb Company (1 from 41 patents)
26 patents:
1. 12012452 - Compositions monovalent for CD28 binding and methods of use
2. 11773175 - Antibodies, uses and methods
3. 11753479 - Nucleic acids encoding anti-OX40L antibodies
4. 11680101 - Anti-OPG antibodies
5. 11396550 - Methods of treating comprising administering anti-OX40L antibodies
6. 10919965 - Compositions monovalent for CD28 binding and methods of use
7. 10669342 - Anti-OX40L antibodies and methods of treating graft versus host disease
8. 10654935 - Methods of treating SLE with anti-OX40L antibodies
9. 10259880 - Anti-LIGHT antibodies
10. 9908937 - Compositions monovalent for CD28 binding and methods of use
11. 9868789 - Synergistic combinations of OX40L antibodies for the treatment of GvHD
12. 9868790 - Synergistic combinations of OX40L antibodies for the treatment of GvHD
13. 9629909 - Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
14. 9587030 - Anti-hOX40L antibodies, uses, and methods
15. 9512229 - Synergistic combinations of OX40L antibodies for the treatment of GVHD